Abstract
Hepatitis C virus (HCV) is a common infection that causes costly liver and extrahepatic complications. Direct-acting antivirals (DAAs) offer >95% cure rates. Patients at high-risk for HCV infection who presented to the emergency department (ED) at UI Health received HCV screening and linkage to DAA treatment. However, HCV screening in the ED is currently not covered by insurance providers. The aim of this study was to assess the long-term cost-effectiveness of routine HCV screening and linkage to care for high-risk patients in the emergency department from the payer’s perspective.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
